Claus Luley
University of Freiburg
55 Papers
810 Citations
Claus Luley is an academic researcher from University of Freiburg. The author has contributed to research in topics: Homocysteine & Cholesterol. The author has an hindex of 26, co-authored 55 publications. Previous affiliations of Claus Luley include Otto-von-Guericke University Magdeburg.
Chat about Author
Papers
Cardiac troponin T predicts mortality in patients with end-stage renal disease.
Jutta Dierkes,Ute Domröse,Sabine Westphal,Andreas Ambrosch,Hans-Peter Bosselmann,K.H. Neumann,Claus Luley +6 more
TL;DR: It is concluded that total homocysteine and particularly cardiac troponin T are important predictors of mortality in patients with end-stage renal disease, whereas other laboratory variables and baseline disease status have less prognostic value.
266
Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n−3 fatty acids
TL;DR: In this paper, a combination of size-exclusion chromatography and fluorometric determination of retinyl palmitate was used to determine whether chylomicrons, chylomerron remnants, and VLDLs are all affected equally or whether some lipoprotein species are lowered preferentially.
112
Extended-release niacin raises adiponectin and leptin.
TL;DR: Short-term treatment with extended-release niacin causes a pronounced increase in adiponectin but fails to improve atheroprotective functions attributed to adiponECTin, such as insulin sensitivity, anti-inflammation and endothelial function.
99
Endothelial dysfunction induced by postprandial lipemia is neutralized by addition of proteins to the fatty meal
Sabine Westphal,Elina Taneva,Steffi Kästner,Jens Martens-Lobenhoffer,Stefanie M. Bode-Böger,Siegfried Kropf,Jutta Dierkes,Claus Luley +7 more
TL;DR: It is suggested that the neutralization of the lipemia-induced endothelial dysfunction is caused by direct and indirect effects of the proteins insulinotropy and, secondly, by an increased supply of L-arginine.
91
Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis.
TL;DR: The efficacy of lovastatin and simvastatin, competitive inhibitors of 3-hydroxy-3-methyl glutaryl coenzyme A reductase, was investigated in 40 hemodialysis patients displaying hypercholesterolemia and moderate hypertriglyceridemia, indicating VLDL formation poor in cholesterol and rich in triglycerides.
87